MOTS-c
← All compounds

MOTS-c

Extensively Studied

First effectsWeek 1-2
Full benefitsWeek 8-12
Category 2

MOTS-c is a peptide produced by your mitochondria. It acts as a hormone-like signal that helps regulate your metabolism, enhance insulin sensitivity, and promote longevity. MOTS-c works through a key energy-sensing pathway (AMPK) and can move into cell nuclei during stress to activate protective genes.

How it works

MOTS-c activates AMPK, your body's master energy sensor, which triggers a cascade of metabolic improvements: better blood sugar regulation, increased fat burning, and improved mitochondrial efficiency. When your cells are under metabolic stress, MOTS-c moves into the nucleus and activates stress-protection genes that boost antioxidant defenses and help cells adapt. This is why it shows benefits for both metabolic health and exercise performance.

Key benefits

  • Improves insulin sensitivity and blood sugar regulation
  • Activates AMPK, your body's master energy sensor
  • Supports mitochondrial health and energy production
  • Enhances exercise performance and recovery
  • Potential longevity and anti-aging benefits

Related goals

Protocols

ProtocolDoseFrequency
Metabolic health5-10mgOnce daily
Anti-aging protocol15mg3x weekly
Exercise performance10-15mgPre-workout
Conservative start5mgOnce daily

Protocols are from published research literature. This is not medical advice. Dosing should be determined by a licensed clinician.

What to expect

Week 1-2

Your body starts responding better to blood sugar. Energy may improve.

Week 2-4

Exercise capacity increases. Insulin sensitivity continues to improve.

Week 4-8

Sustained metabolic benefits. Body composition may start shifting.

Week 8-12

Full mitochondrial benefits. Your body handles energy more flexibly, switching between fuel sources with ease.

What to know

  • Generally well-tolerated in animal studies with minimal side effects
  • Monitor blood glucose if using diabetes medications; may require dose adjustment
  • Limited long-term human safety data - use with appropriate medical supervision
  • May cause mild injection site reactions (redness, swelling)
  • Not recommended during pregnancy or breastfeeding
  • Prohibited by WADA for competitive athletes (metabolic modulator)

Key research

Yang B et al. · Biochimica et Biophysica Acta · 2021
Yin Y et al. · Pharmacological Research · 2021